Re:Big Insurance Met Match When Turned Down a Top Trial Lawy...
by wpasc on Tuesday November 07, 2023 @11:03PM
(#38186639)
https://amp.theguardian.com/society/2016/dec/29/breast-cance...
Itβs not disputed nor unknown that a variety of expensive/newer cancer treatments are not payed for by the NHS. I posted one example but there are many
Re:Big Insurance Met Match When Turned Down a Top Trial Lawy...
by evandijk70 on Wednesday November 08, 2023 @05:10AM
(#38188519)
Bevacizumab (brand name avastin) for metastatic colorectal cancer (standard of care in the Netherlands, approved by the FDA and EMA and recommended by the consensus guidelines of ESMO https://www.esmo.org/guidelines/guidelines-by-topic/esmo-cli...) and is a well known example. See the response of parliament to a petition to change it now that the patent has expired. NHS will still not fund it and cites cost as an important factor https://petition.parliament.uk/petitions/616742?reveal_respo... .
I would note that since funds are limited, any system needs some kind of cost-benefit analysis for drugs to ensure affordability of care. Making this cost-benefit analysis central, transparant, and explicit is probably the best way to do it.
(edit:
I found a speech by Stephen Hawking on the matter:
https://www.hawking.org.uk/in-words/speeches/speech-1
Quick summary: At the start of the speech he refutes a claim that death panels exist in the UK NHS and that they would have let him die. Of course the strongest refutation is the fact that he was at the time -in fact- quite alive; thanks to the NHS.
)